Ypsomed Holding AG (SWX: YPSN)

Market Cap	5.86B
Revenue (ttm)	548.46M
Net Income (ttm)	78.37M
Shares Out	13.65M
EPS (ttm)	5.74
PE Ratio	74.74
Forward PE	50.07
Dividend	2.00 (0.47%)
Ex-Dividend Date	Jul 1, 2024

Volume	7,940
Open	425.50
Previous Close	429.00
Day's Range	416.00 - 428.50
52-Week Range	243.50 - 432.00
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,296
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: YPSN

Financial Performance

In 2023, BANB's revenue was 577.32 million, an increase of 8.57% compared to the previous year's 531.74 million. Earnings were 111.86 million, an increase of 11.10%.